한글목차

요소회로이상증 치료 시장은 2024-2029년 2억 2,740만 달러 증가하고, 예측 기간 동안 3.3%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계의 요소회로이상증 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 요소주기 이상증의 유병률 증가, 노인 환자 증가, 전략적 이니셔티브에 대한 관심 증가에 의해 주도되고 있습니다.

이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

이 보고서는 향후 몇 년동안 요소회로이상증 치료 시장의 성장을 가속하는 주요 요인 중 하나로 신흥국에서의 성장 잠재력 증가를 꼽았습니다. 또한, 조기 검진 및 진단에 대한 기술 발전 증가와 요소주기 이상증 치료에 있어 동반 진단에 대한 요구가 증가함에 따라 시장 수요가 크게 늘어날 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2024
• 시장 전망 2024-2029

제5장 시장 규모 실적

• 세계의 요소회로이상증 치료 시장(2019-2023년)
• 치료별 부문 분석(2019-2023년)
• 투여 경로별 부문 분석(2019-2023년)
• 최종사용자별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 세계의 요소회로이상증 치료 시장

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제8장 시장 세분화 세라피

• 시장 부문
• 비교 : 치료별
• 글리세롤 페닐부틸레이트 : 시장 규모와 예측(2024-2029년)
• 페닐 낙산 나트륨 : 시장 규모와 예측(2024-2029년)
• 아미노산 보충제 : 시장 규모와 예측(2024-2029년)
• 벤조산 나트륨 : 시장 규모와 예측(2024-2029년)
• 기타 : 시장 규모와 예측(2024-2029년)
• 시장 기회 세라피

제9장 시장 세분화 : 투여 경로별

• 시장 부문
• 비교 : 투여 경로별
• 경구 : 시장 규모와 예측(2024-2029년)
• 주사제 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 투여 경로별

제10장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측(2024-2029년)
• 전문 클리닉 : 시장 규모와 예측(2024-2029년)
• 홈케어 : 시장 규모와 예측(2024-2029년)
• 연구기관 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 최종사용자별

제11장 고객 상황

• 고객 상황 개요

제12장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 브라질 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제13장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제14장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제15장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Abbott Laboratories
• Acer Therapeutics Inc.
• Arcturus Therapeutics Holdings Inc.
• Bausch Health Companies Inc.
• Boehringer Ingelheim International GmbH
• CAMP4
• Eurocept B.V.
• Horizon Therapeutics Plc
• Medunik USA
• Orpharma Pty Ltd.
• Recordati S.p.A
• RELIEF THERAPEUTICS Holding SA
• Spyre Therapeutics Inc.
• Synlogic Inc.
• Ultragenyx Pharmaceutical Inc.

제16장 부록

영문목차

The urea cycle disorder treatment market is forecasted to grow by USD 227.4 million during 2024-2029, accelerating at a CAGR of 3.3% during the forecast period. The report on the urea cycle disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of urea cycle disorder, rising geriatric patients, and rising focus on strategic initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's urea cycle disorder treatment market is segmented as below:

By Therapy

• Glycerol phenylbutyrate
• Sodium phenylbutyrate
• Amino acid supplements
• Sodium benzoate
• Others

By Route Of Administration

• Oral
• Injectables

By End-user

• Hospitals
• Specialized clinics
• Home care settings
• Research institutions

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing growth potential in emerging economies as one of the prime reasons driving the urea cycle disorder treatment market growth during the next few years. Also, increasing technological advancements in terms of early screening and diagnosis and growing need for companion diagnostics in treatment of UCD will lead to sizable demand in the market.

The report on the urea cycle disorder treatment market covers the following areas:

• Urea Cycle Disorder Treatment Market sizing
• Urea Cycle Disorder Treatment Market forecast
• Urea Cycle Disorder Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading urea cycle disorder treatment market vendors that include Abbott Laboratories, Acer Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, CAMP4, Dipharma SA, Eurocept B.V., Horizon Therapeutics PLC, Immedica Pharma AB, Medunik USA, Nestle SA, Orpharma Pty Ltd., Reckitt Benckiser Group PLC, Recordati S.p.A, RELIEF THERAPEUTICS Holding SA, Spyre Therapeutics Inc., Swedish Orphan Biovitrum AB, Synlogic Inc., and Ultragenyx Pharmaceutical Inc.. Also, the urea cycle disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Urea Cycle Disorder Treatment Market 2019 - 2023
  • Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2019 - 2023 ($ million)
• 5.2 Therapy segment analysis 2019 - 2023
  • Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
• 5.3 Route of Administration segment analysis 2019 - 2023
  • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Urea Cycle Disorder Treatment Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Therapy

• 8.1 Market segments
  • Chart on Therapy - Market share 2024-2029 (%)
  • Data Table on Therapy - Market share 2024-2029 (%)
• 8.2 Comparison by Therapy
  • Chart on Comparison by Therapy
  • Data Table on Comparison by Therapy
• 8.3 Glycerol phenylbutyrate - Market size and forecast 2024-2029
  • Chart on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
  • Data Table on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
  • Chart on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
  • Data Table on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
• 8.4 Sodium phenylbutyrate - Market size and forecast 2024-2029
  • Chart on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
  • Data Table on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
  • Chart on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
  • Data Table on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
• 8.5 Amino acid supplements - Market size and forecast 2024-2029
  • Chart on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
  • Data Table on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
  • Chart on Amino acid supplements - Year-over-year growth 2024-2029 (%)
  • Data Table on Amino acid supplements - Year-over-year growth 2024-2029 (%)
• 8.6 Sodium benzoate - Market size and forecast 2024-2029
  • Chart on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
  • Data Table on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
  • Chart on Sodium benzoate - Year-over-year growth 2024-2029 (%)
  • Data Table on Sodium benzoate - Year-over-year growth 2024-2029 (%)
• 8.7 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.8 Market opportunity by Therapy
  • Market opportunity by Therapy ($ million)
  • Data Table on Market opportunity by Therapy ($ million)

9 Market Segmentation by Route of Administration

• 9.1 Market segments
  • Chart on Route of Administration - Market share 2024-2029 (%)
  • Data Table on Route of Administration - Market share 2024-2029 (%)
• 9.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 9.3 Oral - Market size and forecast 2024-2029
  • Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Data Table on Oral - Year-over-year growth 2024-2029 (%)
• 9.4 Injectables - Market size and forecast 2024-2029
  • Chart on Injectables - Market size and forecast 2024-2029 ($ million)
  • Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
  • Chart on Injectables - Year-over-year growth 2024-2029 (%)
  • Data Table on Injectables - Year-over-year growth 2024-2029 (%)
• 9.5 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 10.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 10.3 Hospitals - Market size and forecast 2024-2029
  • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
• 10.4 Specialized clinics - Market size and forecast 2024-2029
  • Chart on Specialized clinics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Specialized clinics - Market size and forecast 2024-2029 ($ million)
  • Chart on Specialized clinics - Year-over-year growth 2024-2029 (%)
  • Data Table on Specialized clinics - Year-over-year growth 2024-2029 (%)
• 10.5 Home care settings - Market size and forecast 2024-2029
  • Chart on Home care settings - Market size and forecast 2024-2029 ($ million)
  • Data Table on Home care settings - Market size and forecast 2024-2029 ($ million)
  • Chart on Home care settings - Year-over-year growth 2024-2029 (%)
  • Data Table on Home care settings - Year-over-year growth 2024-2029 (%)
• 10.6 Research institutions - Market size and forecast 2024-2029
  • Chart on Research institutions - Market size and forecast 2024-2029 ($ million)
  • Data Table on Research institutions - Market size and forecast 2024-2029 ($ million)
  • Chart on Research institutions - Year-over-year growth 2024-2029 (%)
  • Data Table on Research institutions - Year-over-year growth 2024-2029 (%)
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.11 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.12 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.14 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.15 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.16 Brazil - Market size and forecast 2024-2029
  • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Acer Therapeutics Inc.
  • Acer Therapeutics Inc. - Overview
  • Acer Therapeutics Inc. - Product / Service
  • Acer Therapeutics Inc. - Key offerings
  • SWOT
• 15.6 Arcturus Therapeutics Holdings Inc.
  • Arcturus Therapeutics Holdings Inc. - Overview
  • Arcturus Therapeutics Holdings Inc. - Product / Service
  • Arcturus Therapeutics Holdings Inc. - Key offerings
  • SWOT
• 15.7 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key news
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
  • SWOT
• 15.8 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 15.9 CAMP4
  • CAMP4 - Overview
  • CAMP4 - Product / Service
  • CAMP4 - Key offerings
  • SWOT
• 15.10 Eurocept B.V.
  • Eurocept B.V. - Overview
  • Eurocept B.V. - Product / Service
  • Eurocept B.V. - Key offerings
  • SWOT
• 15.11 Horizon Therapeutics Plc
  • Horizon Therapeutics Plc - Overview
  • Horizon Therapeutics Plc - Product / Service
  • Horizon Therapeutics Plc - Key offerings
  • SWOT
• 15.12 Medunik USA
  • Medunik USA - Overview
  • Medunik USA - Product / Service
  • Medunik USA - Key offerings
  • SWOT
• 15.13 Orpharma Pty Ltd.
  • Orpharma Pty Ltd. - Overview
  • Orpharma Pty Ltd. - Product / Service
  • Orpharma Pty Ltd. - Key offerings
  • SWOT
• 15.14 Recordati S.p.A
  • Recordati S.p.A - Overview
  • Recordati S.p.A - Business segments
  • Recordati S.p.A - Key offerings
  • Recordati S.p.A - Segment focus
  • SWOT
• 15.15 RELIEF THERAPEUTICS Holding SA
  • RELIEF THERAPEUTICS Holding SA - Overview
  • RELIEF THERAPEUTICS Holding SA - Product / Service
  • RELIEF THERAPEUTICS Holding SA - Key offerings
  • SWOT
• 15.16 Spyre Therapeutics Inc.
  • Spyre Therapeutics Inc. - Overview
  • Spyre Therapeutics Inc. - Product / Service
  • Spyre Therapeutics Inc. - Key offerings
  • SWOT
• 15.17 Synlogic Inc.
  • Synlogic Inc. - Overview
  • Synlogic Inc. - Product / Service
  • Synlogic Inc. - Key offerings
  • SWOT
• 15.18 Ultragenyx Pharmaceutical Inc.
  • Ultragenyx Pharmaceutical Inc. - Overview
  • Ultragenyx Pharmaceutical Inc. - Product / Service
  • Ultragenyx Pharmaceutical Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations